ClassID:

97028

C07K14/705 - page 11 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants

Recent Application in this class:
#3001
20100303818
2010-12-02

Monoclonal antibodies against dendritic cell receptor

#3002
20100303811
2010-12-02

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

#3003
20100303715
2010-12-02

Prostate-specific membrane antigen and uses thereof

#3004
20100299767
2010-11-25

TREM-2 gene and protein as inhibitors of expression of GA733-2, and transgenic animals comprising the same and uses thereof

#3005
20100298225
2010-11-25

PEPTIDE GAP JUNCTION MODULATORS

#3006
20100298217
2010-11-25

CSF-1R MUTANTS

#3007
20100298167
2010-11-25

Cell lines expressing ENaC and methods using them

#3008
20100297702
2010-11-25

Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells

#3009
20100297701
2010-11-25

Trimerizing polypeptides

#3010
20100297674
2010-11-25

NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM

#3011
20100297124
2010-11-25

Induced internalization of surface receptors

#3012
20100297121
2010-11-25

Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists

#3013
20100297093
2010-11-25

MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS

#3014
20100297083
2010-11-25

Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same

#3015
20100292167
2010-11-18

c-MET kinase binding proteins

#3016
20100291556
2010-11-18

Isolated AEBP1 genomic polynucleotide fragments from chromosome 7 and their uses

#3017
20100291127
2010-11-18

Tumor associated antigen peptides and use of same as anti-tumor vaccines

#3018
20100291126
2010-11-18

Protein showing enhanced expression in cancer cells

#3019
20100286233
2010-11-11

PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK

#3020
20100285580
2010-11-11

Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof

#3021
20100285527
2010-11-11

Novel Polypeptide, cDNA Encoding the Same, and Use Thereof

#3022
20100285526
2010-11-11

Compositions and methods for fusion protein separation

#3023
20100284977
2010-11-11

Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters

#3024
20100284908
2010-11-11

Proteins

#3025
20100279928
2010-11-04

Method for inhibiting release of hepatitis B virus from liver cells

#3026
20100279331
2010-11-04

Transporter protein in mammal and utilization of the same

#3027
20100279329
2010-11-04

METHOD FOR THE STABILISATION OF PURIFIED P-GLYCOPROTEIN

#3028
20100279318
2010-11-04

Method of identifying transmembrane protein-interacting compounds

#3029
20100278831
2010-11-04

Nogo receptor-mediated blockade of axonal growth

#3030
20100278792
2010-11-04

METHOD OF ENHANCING PROLIFERATION AND/OR HEMATOPOIETIC DIFFERENTIATION OF STEM CELLS

#3031
20100273990
2010-10-28

Notch-based fusion proteins and uses thereof

#3032
20100273866
2010-10-28

DIAGNOSIS AND TREATMENT OF CANCER: I

#3033
20100273256
2010-10-28

Human Potassium Channel Genes

#3034
20100273190
2010-10-28

PKHDL1, A HOMOLOG OF THE AUTOSOMAL RECESSIVE KIDNEY DISEASE GENE

#3035
20100273182
2010-10-28

Truncated proteins as cancer markers

#3036
20100273174
2010-10-28

Antibodies to tumor associated proteins

#3037
20100272746
2010-10-28

Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins

#3038
20100272742
2010-10-28

NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF

#3039
20100272741
2010-10-28

Immunity to folate receptors

#3040
20100272737
2010-10-28

Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof

#3041
20100272688
2010-10-28

Method of treating or retarding the development of blindness

#3042
20100272647
2010-10-28

RECEPTOR

#3043
20100269180
2010-10-21

METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN

#3044
20100267930
2010-10-21

Slo2, novel potassium channel proteins from human brain

#3045
20100267750
2010-10-21

Methods and compositions for treating pain

#3046
20100267647
2010-10-21

MODULATING PHOTOREACTIVITY IN A CELL

#3047
20100267140
2010-10-21

Soluble inhibitors of vascular endothelial growth factor and use thereof

#3048
20100267133
2010-10-21

Actriib-Fc polynucleotides, polypeptides, and compositions

#3049
20100267129
2010-10-21

Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains

#3050
20100267024
2010-10-21

Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease

#3051
20100266615
2010-10-21

D1-1 NUCLEIC ACIDS, POLYPEPTIDES AND RELATED METHODS

#3052
20100266599
2010-10-21

HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS

#3053
20100266533
2010-10-21

Use of DR3 antibodies in the treatment of inflammatory disease

#3054
20100263064
2010-10-14

Animal model for chronic obstructive pulmonary disease and cystic fibrosis

#3055
20100261880
2010-10-14

LY6H POLYPEPTIDE

#3056
20100261200
2010-10-14

Glycoprotein VI and uses thereof

#3057
20100261191
2010-10-14

Stable cell lines expressing hERG

#3058
20100260761
2010-10-14

ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND

#3059
20100256068
2010-10-07

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

#3060
20100254946
2010-10-07

MAINTENANCE OF HAIR GROWTH AND TREATMENT OF HAIR-LOSS

#3061
20100249372
2010-09-30

Botulinum neurotoxin A receptor and the use thereof

#3062
20100249022
2010-09-30

STRATEGY FOR CLONING AND EXPRESSING THE EXTRACELLULAR DOMAINS OF RECEPTORS AS SOLUBLE PROTEINS

#3063
20100248360
2010-09-30

Human T2R51 taste receptor nucleic acid sequences and polypeptides

#3064
20100248270
2010-09-30

Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease

#3065
20100247542
2010-09-30

Truncated variant of the mammalian target for rapamycin (MTOR) protein

#3066
20100240145
2010-09-23

Hemopoietin receptor protein, NR10

#3067
20100240096
2010-09-23

Hemopoietin receptor protein, NR10

#3068
20100234447
2010-09-16

MODULATION OF GLUCAGON RECEPTOR EXPRESSION

#3069
20100234273
2010-09-16

Delivery of a light-activated cation channel into the brain of a subject

#3070
20100233760
2010-09-16

Protein production in microorganisms of the phylum labyrinthulomycota

#3071
20100233078
2010-09-16

Microorganisms for imaging and/or treatment of tumors

#3072
20100226974
2010-09-09

ANTIBODY RECOGNIZING ANTIGEN

#3073
20100226884
2010-09-09

Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)

#3074
20100223684
2010-09-02

Humanin receptor or humanin-like polypeptide receptor

#3075
20100222261
2010-09-02

Peptidic antagonists of class III semaphorins/neuropilins complexes

#3076
20100221773
2010-09-02

Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof

#3077
20100221724
2010-09-02

Patched polypeptides and uses related thereto

#3078
20100221248
2010-09-02

Directed engagement of activating Fc receptors

#3079
20100221212
2010-09-02

Protease activatable interferon alpha proprotein

#3080
20100216663
2010-08-26

NOVEL PROTEINS WITH TARGETED BINDING

#3081
20100216661
2010-08-26

Diagnostic Assay

#3082
20100216167
2010-08-26

METHODS FOR RELIEVING NEUROPATHIC PAIN BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS AND MICE LACKING ALPHA 1G T-TYPE CALCIUM CHANNELS

#3083
20100216119
2010-08-26

Diagnostic Methods for HIV Infection

#3084
20100215657
2010-08-26

Methods and compositions using FGF23 fusion polypeptides

#3085
20100215655
2010-08-26

ANGIOGENESIS-INHIBITING CHIMERIC PROTEINS AND THE USE

#3086
20100215584
2010-08-26

COMPOSITIONS AND METHODS OF MODULATING THE TASTE AND SMELL RECEPTORS AND SCREENING METHODS THEREFORE

#3087
20100210819
2010-08-19

Biosensors to measure InsP3 concentration in living cells

#3088
20100210517
2010-08-19

Cyclic receptor-associated protein (RAP) peptides

#3089
20100204453
2010-08-12

Antibodies to tumor associated proteins

#3090
20100204103
2010-08-12

HELICAL SYNTHETIC PEPTIDES THAT STIMULATE CELLULAR CHOLESTEROL EFFLUX

#3091
20100204054
2010-08-12

Methods for identifying inhibitors of botulinum neurotoxins

#3092
20100204052
2010-08-12

Protein scaffolds and uses thereof

#3093
20100203548
2010-08-12

Diagnostic method for epilepsy

#3094
20100203109
2010-08-12

Methods and compositions for treating melanoma

#3095
20100199361
2010-08-05

Role of proteoglycans in drug dependence

#3096
20100197580
2010-08-05

Parstatin peptides and uses thereof

#3097
20100197376
2010-08-05

System and method for streaming a lottery game

#3098
20100196960
2010-08-05

Transporter genes OATP-B, C, D, and E

#3099
20100196408
2010-08-05

Metastatic colorectal cancer vaccine

#3100
20100196399
2010-08-05

LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions

#3101
20100196393
2010-08-05

Modulation of blood brain barrier protein expression

#3102
20100196378
2010-08-05

Removal promoters and inhibitor for apoptosis cells in vivo

#3103
20100196351
2010-08-05

SECRETED PATE-LIKE PROTEINS

#3104
20100192239
2010-07-29

Modulation of Mu Delta Opioid Receptor Expression

#3105
20100190962
2010-07-29

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#3106
20100189774
2010-07-29

Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system

#3107
20100189728
2010-07-29

Generation of antigen specific T cells

#3108
20100189713
2010-07-29

Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation

#3109
20100189701
2010-07-29

METHODS AND COMPOSITIONS TO TREAT ARRHYTHMIAS

#3110
20100189686
2010-07-29

Albumin Fusion Proteins

#3111
20100184699
2010-07-22

Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule

#3112
20100184671
2010-07-22

Binding molecules for the treatment of myeloid cell malignancies

#3113
20100184668
2010-07-22

METHOD OF TREATING ABNORMAL ANGIOGENESIS VIA THE BAI FAMILY OF PROTEINS AND THEIR PROTEIN FRAGMENTS

#3114
20100184645
2010-07-22

Stitched polypeptides

#3115
20100184628
2010-07-22

Bis-sulfhydryl macrocyclization systems

#3116
20100184236
2010-07-22

Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37

#3117
20100184096
2010-07-22

Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides

#3118
20100184064
2010-07-22

Ligand gated ion channels from

#3119
20100183702
2010-07-22

Therapies for cancer using RLIP76

#3120
20100183678
2010-07-22

Conjugates of surface proteins as malaria vaccines

#3121
20100183640
2010-07-22

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION

#3122
20100183635
2010-07-22

Glycosylated specificity exchangers

#3123
20100183624
2010-07-22

Methods for increasing adiponectin in a patient in need thereof

#3124
20100183548
2010-07-22

Tweak receptor

#3125
20100174049
2010-07-08

Reversed mammalian protein-protein interaction trap

#3126
20100173972
2010-07-08

METHODS AND USES RELATED TO RHBDL4

#3127
20100173412
2010-07-08

Eukaryotic layered vector initiation systems

#3128
20100173331
2010-07-08

NOVEL NOTCH-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME

#3129
20100173297
2010-07-08

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#3130
20100168026
2010-07-01

Method of treatment of diabestes or reduction in pancreatic beta-cells

#3131
20100168025
2010-07-01

Treatment of stroke using domain V of perlecan

#3132
20100166778
2010-07-01

Toll-like receptor 3 antagonists

#3133
20100166775
2010-07-01

S100A9 interaction screening method

#3134
20100160657
2010-06-24

SYNTHETIC MIMICS OF MAMMALIAN CELL SURFACE RECEPTORS: METHOD AND COMPOSITIONS

#3135
20100160217
2010-06-24

ACETYLYCHOLINE GATED ION CHANNEL CHAPERONS AND METHODS OF USING THE SAME

#3136
20100158947
2010-06-24

Permissive cells and uses thereof

#3137
20100158918
2010-06-24

Polypeptides and polynucleotides encoding same

#3138
20100158807
2010-06-24

RECEPTOR

#3139
20100151476
2010-06-17

Phenylthiocarbamide (PTC) taste receptor

#3140
20100150834
2010-06-17

HIGH AFFINITY EPHB RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF

#3141
20100146645
2010-06-10

TRANSGENIC ANIMAL MODEL FOR MODELLING PATHOLOGICAL ANXIETY, A METHOD FOR IDENTIFYING COMPOUNDS FOR TREATMENT OF DISEASES OR DISORDERS CAUSED BY PATHOLOGICAL ANXIETY AND A METHOD FOR USING WFS1 PROTEIN AS A TARGET FOR IDENTIFYING EFFECTIVE COMPOUNDS AGAINST PATHOLOGICAL ANXIETY

#3142
20100145030
2010-06-10

Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof

#3143
20100144842
2010-06-10

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)

#3144
20100144677
2010-06-10

METHOD FOR SCREENING AGENTS FOR THE TREATMENT OF DIABETES

#3145
20100143381
2010-06-10

LYSOPHOSPHATIDIC ACID RECEPTOR TARGETING FOR LUNG DISEASE

#3146
20100143374
2010-06-10

Diagnostic and therapeutic target for autoimmune diseases and uses thereof

#3147
20100143363
2010-06-10

CD161 ligand, pilar, for modulating activation and proliferation of T cells

#3148
20100137416
2010-06-03

CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH

#3149
20100137207
2010-06-03

G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same

#3150
20100136100
2010-06-03

Removal promoters and inhibitor for apoptosis cells in vivo

#3151
20100136011
2010-06-03

ANTIBODIES THAT BIND TO OBM

#3152
20100136008
2010-06-03

TACI-Fc fusion proteins, methods of making and uses thereof

#3153
20100135991
2010-06-03

ANTIBODIES RECOGNIZING OXYGEN-REGULATED PROTEIN 150 EXPRESSED ON CANCER CELLS AND METHODS OF USING SAME

#3154
20100130419
2010-05-27

Artery- and vein-specific proteins and uses therefor

#3155
20100129438
2010-05-27

Methods and compositions for the treatment and prevention of HIV infection using TRIM5α

#3156
20100129375
2010-05-27

METHODS FOR INHIBITING OCULAR ANGIOGENESIS

#3157
20100129348
2010-05-27

METHOD FOR DECREASING DEPRESSION BY INHIBITING THE ACTIVITY OF ALPHA 1B SUBUNIT OF N-TYPE CALCIUM CHANNEL

#3158
20100120700
2010-05-13

METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER

#3159
20100120172
2010-05-13

SUBSTANCE WITH ANTITHROMBOTIC ACTIVITY AND METHOD FOR DETECTING GLYCOKALLIDIN

#3160
20100120143
2010-05-13

INDUCTION OF APOPTOSIS AND CELL GROWTH INHIBITION BY PROTEIN 4.33

#3161
20100120068
2010-05-13

Methods of using an alpha-1-adrenergic receptor having altered ligand affinity

#3162
20100119513
2010-05-13

Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

#3163
20100119489
2010-05-13

Stimulation of Pancreatic Beta Cell Proliferation

#3164
20100119454
2010-05-13

Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response

#3165
20100119450
2010-05-13

SOLUBLE LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN BINDS DIRECTLY TO ALZHEIMER'S AMYLOID-BETA PEPTIDE

#3166
20100119445
2010-05-13

PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY

#3167
20100115669
2010-05-06

Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof

#3168
20100113750
2010-05-06

Scavenger receptor

#3169
20100113749
2010-05-06

Monoclonal antibody against human scavenger receptor SRCL-P1

#3170
20100112562
2010-05-06

Mutation Implicated in Abnormality of Cardiac Sodium Channel Function

#3171
20100112080
2010-05-06

MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN

#3172
20100111974
2010-05-06

Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereof

#3173
20100107264
2010-04-29

Development of influenza A antivirals

#3174
20100105761
2010-04-29

TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS

#3175
20100105623
2010-04-29

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

#3176
20100104560
2010-04-29

Botulinum neurotoxin E receptors and uses thereof

#3177
20100099182
2010-04-22

System for monitoring the location of transgenes

#3178
20100099105
2010-04-22

Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)

#3179
20100098628
2010-04-22

PROTEINS

#3180
20100098627
2010-04-22

PROTEINS

#3181
20100098626
2010-04-22

Protein

#3182
20100093840
2010-04-15

Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy

#3183
20100093625
2010-04-15

Smoothened polypeptides and methods of use

#3184
20100093623
2010-04-15

COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF

#3185
20100088778
2010-04-08

Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene

#3186
20100087627
2010-04-08

FGFR extracellular domain acidic region muteins

#3187
20100087363
2010-04-08

Glycan modified soluble receptors and binding protein and their use

#3188
20100087358
2010-04-08

NOTCH mutations leading to increased receptor signaling

#3189
20100086487
2010-04-08

Polynucleotides encoding toll-like receptor 3

#3190
20100081709
2010-04-01

Isolated snare YKT6 genomic polynucleotide fragments from chomosome 7 and their uses

#3191
20100080804
2010-04-01

Methods of treating inflammatory disorders of the lungs

#3192
20100076184
2010-03-25

GBS TOXIN RECEPTOR

#3193
20100076063
2010-03-25

Genetic modification of targeted regions of the cardiac conduction system

#3194
20100075908
2010-03-25

Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand

#3195
20100075898
2010-03-25

N-terminal VDAC variants and uses thereof

#3196
20100075412
2010-03-25

T1R taste receptors and genes encoding same

#3197
20100074907
2010-03-25

Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists

#3198
20100069297
2010-03-18

Selective Inhibition of TLR4 Signaling

#3199
20100068763
2010-03-18

MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES

#3200
20100068732
2010-03-18

Cloned glucagon-like peptide-2 receptors

#3201
20100068263
2010-03-18

Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen

#3202
20100068262
2010-03-18

Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen

#3203
20100068175
2010-03-18

Methods of using Fc-cytokine fusion proteins

#3204
20100068145
2010-03-18

Bispecific fusion protein having therapeutic and diagnostic potential

#3205
20100062487
2010-03-11

Methods for identifying compounds which bind to TANGO294

#3206
20100062456
2010-03-11

Nucleic acids encoding T2R taste receptors

#3207
20100062038
2010-03-11

Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts

#3208
20100061992
2010-03-11

THERAPEUTIC USES OF TIM-3 MODULATORS

#3209
20100061974
2010-03-11

Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency

#3210
20100056448
2010-03-04

GLUT-1 as a receptor for HTLV envelopes and its uses

#3211
20100055123
2010-03-04

VACCINE AGAINST BURKHOLDERIA INFECTIONS

#3212
20100055120
2010-03-04

Prostate stem cell antigen (PSCA) variants and subsequences thereof

#3213
20100049847
2010-02-25

System and method for monitoring and analyzing internet traffic

#3214
20100048485
2010-02-25

Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate

#3215
20100048478
2010-02-25

Fn14/TRAIL fusion proteins

#3216
20100047846
2010-02-25

ENDOGENOUS AND NON-ENDOGENOUS VERSIONS OF HUMAN G PROTEIN-COUPLED RECEPTORS

#3217
20100047772
2010-02-25

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES CHARACTERIZED BY A-33 RELATED ANTIGENS

#3218
20100043083
2010-02-18

Insect chemosensory receptors and methods of use thereof

#3219
20100041138
2010-02-18

Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof

#3220
20100035360
2010-02-11

REAGENT FOR DETECTION OF AUTOANTIBODY AND KIT FOR DIAGNOSIS OF AUTOIMMUNE DISEASE

#3221
20100035340
2010-02-11

Variants of human taste receptor genes

#3222
20100034835
2010-02-11

USE OF INHIBITORS OF LEUKOTRIENE B4 RECEPTOR BLT2 FOR TREATING ASTHMA

#3223
20100029917
2010-02-04

Use of ionic liquids for membrane protein extraction

#3224
20100029906
2010-02-04

Synthetic mimics of mammalian cell surface receptors: method and compositions

#3225
20100029749
2010-02-04

Chimeric NK receptor and methods for treating cancer

#3226
20100028929
2010-02-04

Nucleic acid molecules encoding GPR84

#3227
20100028867
2010-02-04

LRRTM1 Compositions and Methods of Their Use for the Diagnosis and Treatment of Cancer

#3228
20100028370
2010-02-04

Receptor associated protein (RAP) conjugates

#3229
20100028327
2010-02-04

Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis

#3230
20100022453
2010-01-28

NoGo Receptor 1 and Fibroblast Growth Factor Interactions

#3231
20100022028
2010-01-28

Antibodies that bind human OX2 receptors

#3232
20100021982
2010-01-28

LIGHT-SENSITIVE CONSTRUCTS FOR INDUCING CELL DEATH AND CELL SIGNALING

#3233
20100021510
2010-01-28

Neuronal exocytosis inhibiting peptides

#3234
20100021467
2010-01-28

METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL

#3235
20100021383
2010-01-28

Molecular probe for sphingolipids

#3236
20100017901
2010-01-21

Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use

#3237
20100017897
2010-01-21

PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis

#3238
20100016552
2010-01-21

Hemopoietic receptor protein, NR10

#3239
20100015640
2010-01-21

Nucleic acid sequences and their use in methods to identify umami modulatiors

#3240
20100015159
2010-01-21

Compositions and methods for treating kidney disease

#3241
20100015125
2010-01-21

METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE MEMORY BY BLOCKING INTRAHEPATIC ACTIVATED T CELL DELETION

#3242
20100015108
2010-01-21

Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA

#3243
20100015095
2010-01-21

Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids

#3244
20100009461
2010-01-14

NPC1L1 (NPC3) and methods of identifying ligands thereof

#3245
20100009444
2010-01-14

System and method for controlling G-protein coupled receptor pathways

#3246
20100009363
2010-01-14

RBP4 in insulin sensitivity/resistance, diabetes, and obesity

#3247
20090325887
2009-12-31

Peptides and regulation of calcium channels

#3248
20090325708
2009-12-31

Biometric broadband gaming system and method

#3249
20090324644
2009-12-31

CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS

#3250
20090324627
2009-12-31

Isolated DNA directed 50kD regulatory subunit (POLD2) genomic polynucleotide fragments from chomosome 7 and their uses

#3251
20090324626
2009-12-31

Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses

#3252
20090324615
2009-12-31

METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION

#3253
20090324597
2009-12-31

ULBP antibodies

#3254
20090324566
2009-12-31

T-cell receptor and nucleic acid encoding the receptor

#3255
20090318672
2009-12-24

Antibodies to PRO352

#3256
20090318340
2009-12-24

IL-17 homologous polypeptides and therapeutic uses thereof

#3257
20090317905
2009-12-24

Mutations in ion channel proteins associated with sudden cardiac death

#3258
20090317858
2009-12-24

CELLULAR ASSAYS FOR SIGNALING RECEPTORS

#3259
20090317811
2009-12-24

Two pore channels as regulators of proliferation in cancer

#3260
20090317332
2009-12-24

Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity

#3261
20090313709
2009-12-17

Genetically Modified Animal and Use Thereof

#3262
20090313708
2009-12-17

GPR22 AND METHODS RELATING THERETO

#3263
20090312253
2009-12-17

Methods of effecting Wnt signaling through Dkk structural analysis

#3264
20090312249
2009-12-17

TLR4 decoy receptor protein

#3265
20090311261
2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#3266
20090311260
2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#3267
20090311256
2009-12-17

12 human secreted proteins

#3268
20090311225
2009-12-17

Compositions of and Methods of Using Stabilized PSMA Dimers

#3269
20090307791
2009-12-10

CALCIUM-ACTIVATED CHLORIDE CHANNEL AND METHODS OF USE THEREOF

#3270
20090305982
2009-12-10

Muteins of tear lipocalin and methods for obtaining the same

#3271
20090305981
2009-12-10

Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers

#3272
20090305972
2009-12-10

Cancer-associated antigen

#3273
20090305971
2009-12-10

Nogo-B receptor antagonists

#3274
20090305949
2009-12-10

GLYCOSYLATED SPECIFICITY EXCHANGER

#3275
20090305270
2009-12-10

ANTIGENIC SURFACE STRUCTURE OF SPERM CELLS ASSOCIATED WITH THE Y CHROMOSOME

#3276
20090304588
2009-12-10

BIOLOGICALLY EXCITABLE CELLS

#3277
20090297531
2009-12-03

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

#3278
20090297527
2009-12-03

Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use

#3279
20090297498
2009-12-03

Milk fat globule epidermal growth factor—factor VIII and sepsis

#3280
20090288176
2009-11-19

Novel Gene Disruptions, Compositions and Methods Relating Thereto

#3281
20090286954
2009-11-19

Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use

#3282
20090286713
2009-11-19

Collagen Receptor I-Domain Binding Modulators

#3283
20090286262
2009-11-19

Chimeric proteins and their use in methods to screen for sweet taste modulators

#3284
20090285843
2009-11-19

EPITOPE SEQUENCES

#3285
20090285816
2009-11-19

Albumin Fusion Proteins

#3286
20090285801
2009-11-19

Calcium-sensing receptor 2 (CaR2) and methods for using

#3287
20090281024
2009-11-12

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

#3288
20090280560
2009-11-12

Yeast cell surface display of proteins and uses thereof

#3289
20090280506
2009-11-12

Methods for identifying modulators of SF taste receptor signaling

#3290
20090280455
2009-11-12

Interactive dental restorative network

#3291
20090280092
2009-11-12

G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells

#3292
20090275738
2009-11-05

Use of A33 antigens and JAM-IT

#3293
20090275125
2009-11-05

Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids

#3294
20090274699
2009-11-05

UL16 binding protein 4

#3295
20090274684
2009-11-05

Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease

#3296
20090274669
2009-11-05

Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use

#3297
20090270322
2009-10-29

G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same

#3298
20090269842
2009-10-29

Transmembrane delivery peptide and bio-material comprising the same

#3299
20090269346
2009-10-29

Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof

#3300
20090264628
2009-10-22

CRYSTAL STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR AMINO TEMINAL FRAGMENT BOUND TO ITS RECEPTOR